ab65233 detects endogenous levels of total UBXD5 protein.
Synthetic peptide derived from an internal sequence of human UBXD5.
Human lung carcinoma tissue and HepG2 cell extracts.
Shipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.
Preservative: 0.02% Sodium Azide
Constituents: 50% Glycerol, PBS (without Mg 2+ and Ca 2+), 150mM Sodium chloride, pH 7.4
Concentration information loading...
Immunogen affinity purified
Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
1/50 - 1/100.
1/500 - 1/1000. Detects a band of approximately 57 kDa (predicted molecular weight: 57 kDa).
UBXD5, UBX domain containing protein 5, is a Rnd GTPase-interacting protein and may be involved in the reorganization of actin cytoskeleton. It also promotes RHOA activation mediated by GNA12 and GNA13.
COA 1 antibody
colorectal tumor associated antigen 1 antibody
Colorectal tumor associated antigen COA 1 antibody
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-UBXD5 antibody (ab65233)
ab65233 at 1/50 dilution staining UBXD5 in human lung carcinoma by Immunohistochemistry, Paraffin-embedded tissue, in the absence or presence of the immunising peptide.
Western blot - Anti-UBXD5 antibody (ab65233)
All lanes : Anti-UBXD5 antibody (ab65233) at 1/500 dilution Lane 1 : HepG2 cell extract Lane 2 : HepG2 cell extract with immunising peptide at 5 µg Lysates/proteins at 5 µg per lane. Predicted band size: 57 kDa Observed band size: 57 kDa
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"